Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 10,000 shares at $0.90 ($9,000)
  5. 4 Open-market buy President & CEO bought 10,000 shares at an average $0.88 ($8,797)
  6. 4 Open-market buy Director bought 10,000 shares at an average $0.88 ($8,776)
  7. 4 Option exercise President and CEO acquired 5,995 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Exercise or conversion VP, Finance & CFO acquired 2,000 shares (option exercise)
  14. 3/A Insider 3/A
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Director sold 210,000 shares at $3.10 ($651,000)
  18. 4 Open-market buy Director bought 4,500 shares at $3.26 ($14,670)
  19. 4 Open-market buy Director bought 400 shares at $3.16 ($1,264)
  20. 4 Open-market buy Director bought 400 shares at an average $3.52 ($1,408)

Page 11 of 24 · 471 filings